SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hikal Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524735

INE475B01022

96.8412723

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HIKAL

83.13

2080.7

EPS(TTM)

Face Value()

Div & Yield %

2.03

0.47

Back

Religare Enterprises Ltd - Clarification Letter For Clerical And Typographical Error In The Letter Dated July 11 2025 Intimating The Grant Of Esops By Religare Enterprises Ltd.

Oct 01,2025

Clarification Letter for clerical and typographical error in the letter dated July 11 2025 intimating the grant of ESOPs by Religare Enterprises Ltd.

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)